Substance

ID:183124

Guanosine 3′,5′-cyclic monophosphate

Names and Identifiers
IUPAC name
2-amino-9-{2,7-dihydroxy-2-oxo-hexahydro-1,3,5,2λ5-furo[3,2-d][1,3,2λ5]dioxaphosphinin-6-yl}-6,9-dihydro-3H-purin-6-one
Synonyms
cyclic GMPcGMPGuanosine 3′,5′-cyclic monophosphate
IUPAC Traditional name
cyclic guanosine monophosphate
Registration numbers
MDL Number
CAS Number
PubChem SID
EC Number
Properties
Product Information
Purity
≥98% (HPLC)
Safety Information
GHS Pictograms
GHS07
Acute toxicity (oral, dermal, inhalation), category 4
Skin irritation, category 2
Eye irritation, category 2
Skin sensitisation, category 1
Specific Target Organ Toxicity – Single exposure, category 3
GHS Signal Word
Warning
GHS Hazard statements
H315-H319-H335
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
GHS Precautionary statements
P261-P305+P351+P338
Safety Statements
22-26-36
Storage Temperature
-20°C
Risk Statements
36/37/38
European Hazard Symbols
Irritant Irritant (Xi)
German water hazard class
3
Physical Property
Solubility
1% NaHCO3: soluble50 mg/mL
Apperance
white powder
Molecule Details
Biochem/physiol Actions
An important second messenger, cGMP is a major intracellular mediator of extracellular signals such as nitric oxide and natriuretic peptides. Cyclic GMP interacts with three types of intracellular receptor proteins: cGMP-dependent protein kinases, cGMP-regulated channels, and cGMP-regulated cyclic nucleotide phosphodiesterases. A primary action of elevated cGMP levels in vivo is the stimulation of cGMP-dependent protein kinase (PKG).
Other Notes
Tandem Mass Spectrometry data independently generated by Scripps Center for Metabolomics is available to view or download in PDF. G7504.pdf Tested metabolites are featured on Scripps Center for Metabolomics METLIN Metabolite Database. To learn more, visit sigma.com/metlin.
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data